CBOE · UNOV

Innovator U. S. Equity Ultra Buffer – November

$40.23 +$0.09 (+0.22%) 1D Market open
Charting by TradingView

Key Metrics

$12.19B
Market cap
3,356.41×
P/E · TTM
$35.70M
Revenue · TTM
$3.63M
Net income
EPS · TTM $0.01
Dividend yield —
Free cash flow $1.18M
Beta · 1Y 0.43
EBITDA · TTM $3.31M
Gross margin 71.4%

Snapshot

Market cap—
Enterprise value—
Shares outstanding—
52-wk range$35.85 – $40.48
Avg volume · 20D18.4K
Net cash —
Book value / share$0.02
IndustryPharmaceutical Preparations
ExchangeCBOE
About Innovator U. S. Equity Ultra Buffer – November
IPO dateOct 31, 2019
Employees—

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E3,356.41
P/S341.40
P/FCF10,290.44
EV/EBITDA—
EV/Sales—
Graham №$0.08

Profitability

Gross 71.4%
Operating 8.7%
Net 10.2%
FCF 3.3%
ROE / ROIC 66.9% · 58.0%

Financial Health

Current ratio1.93
Quick ratio1.58
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$1.79M

Cash Flow · TTM

Operating CF $1.94M
Capex −$756.62K
Free cash flow $1.18M
Buybacks $471.41K
Dividends paid —
Shareholder yield 0.0%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

3,792.9
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$0.08 vs $40.15
Trades 509.2× above classic defensive value — priced for growth
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings